ALLO
Price
$2.91
Change
+$0.03 (+1.04%)
Updated
Sep 19 closing price
41 days until earnings call
AUTL
Price
$3.85
Change
-$0.02 (-0.52%)
Updated
Sep 19 closing price
41 days until earnings call
Ad is loading...

ALLO vs AUTL

Header iconALLO vs AUTL Comparison
Open Charts ALLO vs AUTLBanner chart's image
Allogene Therapeutics
Price$2.91
Change+$0.03 (+1.04%)
Volume$4.74M
CapitalizationN/A
Autolus Therapeutics
Price$3.85
Change-$0.02 (-0.52%)
Volume$764.06K
CapitalizationN/A
View a ticker or compare two or three
ALLO vs AUTL Comparison Chart
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
AUTL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ALLO vs. AUTL commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and AUTL is a Sell.

COMPARISON
Comparison
Sep 20, 2024
Stock price -- (ALLO: $2.88 vs. AUTL: $3.87)
Brand notoriety: ALLO and AUTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 108% vs. AUTL: 134%
Market capitalization -- ALLO: $602.24M vs. AUTL: $1.03B
ALLO [@Biotechnology] is valued at $602.24M. AUTL’s [@Biotechnology] market capitalization is $1.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $585.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileAUTL’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • AUTL’s FA Score: 0 green, 5 red.
According to our system of comparison, AUTL is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 6 TA indicator(s) are bullish while AUTL’s TA Score has 3 bullish TA indicator(s).

  • ALLO’s TA Score: 6 bullish, 3 bearish.
  • AUTL’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than AUTL.

Price Growth

ALLO (@Biotechnology) experienced а -1.03% price change this week, while AUTL (@Biotechnology) price change was -5.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.38%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1.46%.

Reported Earning Dates

ALLO is expected to report earnings on Oct 31, 2024.

AUTL is expected to report earnings on Oct 31, 2024.

Industries' Descriptions

@Biotechnology (+7.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUTL($1.03B) has a higher market cap than ALLO($602M). ALLO YTD gains are higher at: -10.280 vs. AUTL (-39.907). AUTL has higher annual earnings (EBITDA): -162.54M vs. ALLO (-256.56M). AUTL has more cash in the bank: 706M vs. ALLO (445M). AUTL has less debt than ALLO: AUTL (50M) vs ALLO (87M). AUTL has higher revenues than ALLO: AUTL (10.5M) vs ALLO (65K).
ALLOAUTLALLO / AUTL
Capitalization602M1.03B58%
EBITDA-256.56M-162.54M158%
Gain YTD-10.280-39.90726%
P/E RatioN/AN/A-
Revenue65K10.5M1%
Total Cash445M706M63%
Total Debt87M50M174%
FUNDAMENTALS RATINGS
ALLO vs AUTL: Fundamental Ratings
ALLO
AUTL
OUTLOOK RATING
1..100
2361
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
5758
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AUTL's Valuation (47) in the Biotechnology industry is somewhat better than the same rating for ALLO (97). This means that AUTL’s stock grew somewhat faster than ALLO’s over the last 12 months.

AUTL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ALLO (100). This means that AUTL’s stock grew similarly to ALLO’s over the last 12 months.

ALLO's SMR Rating (96) in the Biotechnology industry is in the same range as AUTL (98). This means that ALLO’s stock grew similarly to AUTL’s over the last 12 months.

ALLO's Price Growth Rating (57) in the Biotechnology industry is in the same range as AUTL (58). This means that ALLO’s stock grew similarly to AUTL’s over the last 12 months.

ALLO's P/E Growth Rating (100) in the Biotechnology industry is in the same range as AUTL (100). This means that ALLO’s stock grew similarly to AUTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALLOAUTL
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 15 days ago
83%
Declines
ODDS (%)
Bearish Trend 14 days ago
86%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
AUTL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAFLX13.010.01
+0.08%
Lord Abbett Focused Large Cap Value A
TEPLX27.47-0.02
-0.07%
Templeton Growth A
GCIRX14.67-0.03
-0.20%
Goldman Sachs Intl Eq Insghts R
SNTFX21.02-0.06
-0.28%
Steward International Enhanced Index R6
MFVSX19.58-0.08
-0.41%
MassMutual Equity Opports R5

AUTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with ACLX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
+0.78%
ACLX - AUTL
43%
Loosely correlated
+3.28%
VCYT - AUTL
36%
Loosely correlated
-1.63%
ALLO - AUTL
35%
Loosely correlated
N/A
RCKT - AUTL
35%
Loosely correlated
-4.40%
GOSS - AUTL
34%
Loosely correlated
+1.38%
More